Skip to main content
AR

Artelo Biosciences

La Jolla, United States
Last funding
$11.0M
Post-IPO EquityMar 2026

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Backed byBartosz Lipiński

About Artelo Biosciences

How much funding has Artelo Biosciences raised?

Artelo Biosciences has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.

Who are Artelo Biosciences's investors?

Artelo Biosciences's investors include Bartosz Lipiński.

Where is Artelo Biosciences headquartered?

Artelo Biosciences is headquartered in La Jolla, United States.

What does Artelo Biosciences do?

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

What stage is Artelo Biosciences at?

Artelo Biosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Artelo Biosciences — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/artelo-biosciences. Accessed November 15, 2026.
APA
VCBacked. (2026). Artelo Biosciences — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/artelo-biosciences
Wikipedia (cite web)
{{cite web |title=Artelo Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/artelo-biosciences |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Artelo Biosciences? Request a listing update

Founder contacts
m***@artelobio.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →